| Company Name: | Radiologix, Incorporated | | Ticker Symbol: | RGX | | | WWW Address: | www.radiologix.com | | CEO: | Sami S. Abbasi | | No. of Employees: | 2,159 | | Common Issue Type: | CS | | Business Description: | The Company is a national provider of diagnostic imaging services. It utilize sophisticated technology to perform a broad range of imaging procedures, such as MRI, CT, PET, nuclear medicine, ultrasound, mammography, DEXA, X-ray and fluoroscopy.
|
| | | Industry Information: | HEALTH SERVICES - Medical Laboratories & Research [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | |  | - | - | 0 | 4.30 | 4.21 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 95.6 | 22.2 | 1.83 | -0.07 | 0.00 | 0.0 | 0.0 | 4.30 - 1.40 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 4.30 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 95.6 | mil |
| Latest Shares Outstanding | 22.2 | mil |
| Earnings pS (EPS) | -0.07 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 116,461 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 19.8 | mil |
| Float as % of Shares Outstanding | 89.1 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 16.30 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 34.4 | % |
| EBITDA Margin | 18.1 | % |
| Pre-Tax Profit Margin | 0.3 | % |
| Assets Turnover | 1.0 | % |
| Return on Assets (ROA) | -0.2 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -0.2 | % |
| Current Ratio | 3.9 | |
| Leverage Ratio (Assets/Equity) | 7.4 | |
| Interest Cover | 1.0 | |
| Total Debt/Equity (Gearing Ratio) | 5.32 | |
| LT Debt/Total Capital | 84.0 | % |
| Working Capital pS | 3.42 | $ |
| Cash pS | 1.96 | $ |
| Book-Value pS | 1.44 | $ |
| Tangible Book-Value pS | -0.92 | $ |
| Cash Flow pS | 1.11 | $ |
| Free Cash Flow pS | 0.06 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.99 | |
| Price/Tangible Book Ratio | -4.67 | |
| Price/Cash Flow | 3.9 | |
| Price/Free Cash Flow | 71.7 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 5.9 | 105 | 1,010 | 6,376 |
| 4 Weeks | 4.30 | 3.82 | 4.05 | 6.2 | 105 | 1,179 | 23,589 |
| 13 Weeks | 4.30 | 3.10 | 3.20 | 34.4 | 123 | 1,130 | 72,309 |
| 26 Weeks | 4.30 | 1.75 | 2.32 | 85.3 | 173 | 1,236 | 157,002 |
| 52 Weeks | 4.30 | 1.40 | 3.24 | 32.7 | 119 | 1,071 | 268,697 |
| YTD | 4.30 | 1.40 | - | 41.0 | 127 | 1,181 | 257,535 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 4.21 | 4.13 | 4.00 | 3.05 | 2.71 | 1.83 | 1.92 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -1.81 | 45.1 | -1.17 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 16.17 | NA | 8.69 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 2.5 | 1.3 | 0.1 |
| Earnings % | 95.1 | -62.9 | 0.0 |
| EPS % | 100.0 | -66.7 | 0.0 |
| EPS $ | 0.05 | -0.02 | 0.76 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 30.06 |
| Current Ratio | 3.8 |
| Quick Ratio (Acid Test) | 3.3 |
| Liquidity Ratio (Cash) | 1.64 |
| Receivables Turnover | 5.2 |
| Average Collection Period | 69 |
| Working Capital/Equity | 243.4 |
| Working Capital pS | 3.17 |
| Cash-Flow pS | 1.06 |
| Free Cash-Flow pS | 0.04 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.01 |
| Financial Leverage Ratio (Assets/Equity) | 8.1 |
| Debt Ratio | 87.6 |
| Total Debt/Equity (Gearing Ratio) | 5.88 |
| LT Debt/Equity | 5.88 |
| LT Debt/Capital Invested | 90.4 |
| LT Debt/Total Liabilities | 82.9 |
| Interest Cover | 1.0 |
| Interest/Capital Invested | 8.75 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 3.69 |
| Tobin's Q Ratio | 0.41 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 6.00 |
| Enterprise Value (EV)/Free Cash Flow | 363.16 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -4.67 |
| Price/Book Ratio - LTM | 2.99 |
| Price/Cash Flow Ratio | 3.9 |
| Price/Free Cash Flow Ratio - LTM | 71.7 |
| Price/Sales Ratio | 0.38 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 25.3 |
| PER SHARE FIGURES |
| LT Debt pS | 7.66 |
| Current Liabilities pS | 1.14 |
| Tangible Book Value pS - LTM | -0.92 |
| Book Value pS - LTM | 1.44 |
| Capital Invested pS | 8.96 |
| Cash pS - LTM | 1.96 |
| Cash Flow pS - LTM | 1.11 |
| Free Cash Flow pS - LTM | 0.06 |
| Earnings pS (EPS) | -0.07 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 0.33 |
| Free Cash Flow Margin 5YEAR AVG | 4.11 |
| Net Profit Margin | -0.6 |
| Net Profit Margin - 5YEAR AVRG. | 0.0 |
| Equity Productivity | 8.68 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.26 |
| Return on Capital Invested (ROCI) | -0.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 0.0 |
| Assets Productivity | 1.00 |
| Return on Assets (ROA) | -0.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | 0.0 |
| Gross Profit Margin | 34.4 |
| Gross Profit Margin - 5YEAR AVRG. | 50.0 |
| EBITDA Margin - LTM | 18.1 |
| EBIT Margin - LTM | 7.3 |
| Pre-Tax Profit Margin | 0.4 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 2.5 |
| Effective Tax Rate | 74.0 |
| Effective Tax Rate - 5YEAR AVRG. | 51.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 67 |
| Revenue per Employee | 116,461 |
| Net Income per Employee | -709 |
| Average Collection Period | 67 |
| Receivables Turnover | 5.2 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 4.04 |
| Assets/Revenue | 1.00 |
| Net Working Capital Turnover | 3.57 |
| Fixed Assets Turnover | 1.81 |
| Total Assets Turnover | 1.0 |
| Revenue per $ Cash | 6.98 |
| Revenue per $ Plant | 3.70 |
| Revenue per $ Common Equity | 8.68 |
| Revenue per $ Capital Invested | 1.26 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 14.3 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 31.6 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |